HHS’s “Ready, Set, PrEP” program will provide free HIV prevention drugs to 200,000 uninsured Americans at risk for HIV. Although the program expands both access and use, costly medical appointments and tests to qualify for and renew prescriptions are not covered.
Want to dig deeper into critical access issues?
-
Article
From Market Authorization to Patient Access: EFPIA Patients W.A.I.T. Indicator
Read Now
Edith Frenoy
Global Forum -
Video
Improving Communication and Access to Meet Patient Needs
Watch Now
Sissi Pham -
Article
Many Obstacles, Many Opportunities: Rare Disease Drug Accessibility and Social Medical Coverage in China
Read Now
Kevin Rufang Huang
Global Forum -
Article
Combatting Fragmentation in Access to Medicines
Read Now
Adam Istas
Global Forum -
Video
Sustainability of Healthcare Funding
Watch Now
Kenneth Kaitin, Luca Pani -
Article
Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes?
Read Now
Elizabeth Richardson et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Podcast
EUnetHTA: Post-Launch Critical for Comparative Data
Listen Now
Niklas Hedberg -
Article
Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug
Read Now
Arthur Caplan et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more?
Plan to attend sessions in the Value & Access track at DIA Europe 2020 in Brussels, or review the members-only Value & Access resources from our DIA 2019 Global Annual Meeting.
Related Perspectives
View all Deep Dives-
Article
From FiercePharma: Gilead, seeking HIV patent extension, faces 'gamesmanship' claims from patient group
Read Now -
Article
From NPR: HIV Prevention Drugs Are Available For Free: How Do You Get Them?
Read Now -
Article
From The New York Times: FDA Approves New HIV-Prevention Drug, but Not for Everyone
Read Now -
Article
From HIV.gov: Pre-Exposure Prophylaxis
Read Now